| Net income | 342M |
| Depreciation and amortization | 28M |
| Gain on sale of property, plant, and equipment | |
| Stock-based compensation expense | 7M |
| Deferred income taxes | |
| Changes in assets and liabilities | -201M |
| Cash provided by operating activities | |
| Proceeds from sale of property, plant, and equipment | |
| Additions to property, plant, and equipment | -36M |
| Acquisition of brand names and trademarks | |
| Computer software expenditures | -1M |
| Cash provided by (used for) investing activities | |
| Net increase in short-term borrowings | 6M |
| Repayment of long-term debt | |
| Net payments related to exercise of stock-based awards | |
| Excess tax benefits from stock-based awards | 0 |
| Acquisition of treasury stock | -442M |
| Dividends paid | -134M |
| Cash used for financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | -14M |
| Net increase (decrease) in cash and cash equivalents | -52M |
| Cash and cash equivalents, beginning of period | 263M |
| Cash and cash equivalents, end of period | 211M |